These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1877820

  • 1. [Chemotherapy in malignant gynecologic tumors using intraperitoneal catheter with a subcutaneous reservoir].
    Shimizu A, Kimura T, Funatsu M, Hada Y, Araki H, Notake Y.
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1795-9. PubMed ID: 1877820
    [Abstract] [Full Text] [Related]

  • 2. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
    Hirashima Y, Shimura T, Tanaka Y, Demukai H, Kubota T, Kobayashi T, Suzuki A.
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
    [Abstract] [Full Text] [Related]

  • 3. [Significance and effects of intraperitoneal cisplatin administration for ovarian cancer].
    Shimizu A, Ookubo K, Hasegawa J, Endoh T, Fujiwara O, Yoda A, Okuyama D, Narabayashi A, Kimura T, Takahashi J, Notake Y.
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1801-5. PubMed ID: 10560398
    [Abstract] [Full Text] [Related]

  • 4. [Intraperitoneal chemotherapy using CBDCA for malignant gynecological tumors].
    Shimizu A, Kimura T, Funatsu M, Hada Y, Tamura K, Taguchi A, Miyakawa Z, Notake Y.
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1738-41. PubMed ID: 1530345
    [Abstract] [Full Text] [Related]

  • 5. [Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy].
    Noda T, Adachi S, Yamamoto T, Hirooka C, Kiyozuka Y, Adachi S, Oku M, Ichijo M.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1561-8. PubMed ID: 2389949
    [Abstract] [Full Text] [Related]

  • 6. Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.
    Makhija S, Sabbatini P, Aghajanian C, Venkatraman E, Spriggs DR, Barakat R.
    Gynecol Oncol; 2000 Oct; 79(1):28-32. PubMed ID: 11006026
    [Abstract] [Full Text] [Related]

  • 7. [CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
    Hasegawa Y, Honnma S, Takanashi K, Yajima K, Nakashima Y.
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):2047-51. PubMed ID: 1908669
    [Abstract] [Full Text] [Related]

  • 8. [The value of a Tenckhoff catheter in ovarian cancer].
    Kato N, Arakawa A, Yasui Y, Suzumori K, Suzumori K, Yagami Y.
    Gan To Kagaku Ryoho; 1991 May; 18(6):1025-30. PubMed ID: 2029187
    [Abstract] [Full Text] [Related]

  • 9. [Intraperitoneal chemotherapy for gastric carcinoma combined with peritoneal dissemination by intraperitoneal catheter with a subcutaneous reservoir].
    Kurita A, Takashima S, Takayama T, Doihara H.
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2439-44. PubMed ID: 7944489
    [Abstract] [Full Text] [Related]

  • 10. [An aged patient with stage IV ovarian cancer successfully treated by intraperitoneal consecutive administration of cisplatin].
    Narimatsu A, Okada O.
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1225-9. PubMed ID: 9679588
    [Abstract] [Full Text] [Related]

  • 11. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Walker JL, Armstrong DK, Huang HQ, Fowler J, Webster K, Burger RA, Clarke-Pearson D.
    Gynecol Oncol; 2006 Jan; 100(1):27-32. PubMed ID: 16368440
    [Abstract] [Full Text] [Related]

  • 12. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
    Royer B, Delroeux D, Guardiola E, Combe M, Hoizey G, Montange D, Kantelip JP, Chauffert B, Heyd B, Pivot X.
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
    [Abstract] [Full Text] [Related]

  • 13. [Intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis using totally implantable peritoneal access system].
    Tokushige M, Takao S, Hokita S, Maenohara S, Aikou T, Shimazu H.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2743-7. PubMed ID: 2782886
    [Abstract] [Full Text] [Related]

  • 14. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai Gynecology Study Group (SGSG) study.
    Miyagi Y, Fujiwara K, Kigawa J, Itamochi H, Nagao S, Aotani E, Terakawa N, Kohno I, Sankai Gynecology Study Group (SGSG).
    Gynecol Oncol; 2005 Dec; 99(3):591-6. PubMed ID: 16095677
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacokinetics and toxicological study on the intraperitoneal administration of cisplatin and etoposide in gynecological malignancies].
    Fujimoto R, Yanagawa Y, Yamada T, Ueki K, Takahara T, Kumagai K, Okamura S, Ueki M, Sugimoto O.
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1843-9. PubMed ID: 1519927
    [Abstract] [Full Text] [Related]

  • 16. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.
    Sakuragi N, Nakajima A, Nomura E, Noro N, Yamada H, Yamamoto R, Fujimoto S.
    Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613
    [Abstract] [Full Text] [Related]

  • 17. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest.
    Gadducci A, Carnino F, Chiara S, Brunetti I, Tanganelli L, Romanini A, Bruzzone M, Conte PF.
    Gynecol Oncol; 2000 Feb; 76(2):157-62. PubMed ID: 10637064
    [Abstract] [Full Text] [Related]

  • 18. [Intraperitoneal chemotherapy of metastatic ovarian cancer].
    Hasegawa E, Watanabe H, Ohmura G, Hirakawa S, Momose K.
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1742-4. PubMed ID: 1530346
    [Abstract] [Full Text] [Related]

  • 19. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
    Berry E, Matthews KS, Singh DK, Buttin BM, Lurain JR, Alvarez RD, Schink J.
    Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
    [Abstract] [Full Text] [Related]

  • 20. [The effect of intraperitoneal and intra-aortic chemotherapy for unresectable gastric cancer].
    Kawasaki S, Nagai K, Maruyama S, Murakami M, Yoshizane K, Morokoshi Y, Kawai K, Yamamoto M, Soda M.
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2256-9. PubMed ID: 7944453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.